{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:48:26Z","timestamp":1791488906474,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","onlinejacc.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jacc.2017.07.755","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T19:46:19Z","timestamp":1504554379000},"page":"1325-1335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":170,"title":["Care Patterns and Outcomes in Atrial\u00a0Fibrillation Patients With and Without Diabetes"],"prefix":"10.1016","volume":"70","author":[{"given":"Justin B.","family":"Echouffo-Tcheugui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Shrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laine","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Kowey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Mahaffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M.","family":"Hylek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Piccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2017.07.755_bib1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2017.07.755_bib2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.07.755_bib3","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics\u20132017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2017.07.755_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCOUTCOMES.110.958165","article-title":"Estimation of total incremental health care costs in patients with atrial fibrillation in the United States","volume":"4","author":"Kim","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2017.07.755_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCOUTCOMES.111.962688","article-title":"Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993\u20132007","volume":"5","author":"Piccini","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2017.07.755_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1538-7836.2010.04085.x","article-title":"A\u00a0comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice","volume":"9","author":"Van Staa","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2017.07.755_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","article-title":"Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation","volume":"108","author":"Huxley","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2017.07.755_bib8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jamacardio.2016.5224","article-title":"Atrial fibrillation, type 2 diabetes, and non-vitamin K antagonist oral anticoagulants: a review","volume":"2","author":"Plitt","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2017.07.755_bib9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/archinte.1997.00440320143013","article-title":"The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2017.07.755_bib10","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/STROKEAHA.115.009371","article-title":"Duration of diabetes mellitus and risk of thromboembolism and bleeding in atrial fibrillation: Nationwide Cohort Study","volume":"46","author":"Overvad","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2017.07.755_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jacc.2015.10.080","article-title":"Effect of diabetes and glycemic control on ischemic stroke risk in AF patients","volume":"67","author":"Ashburner","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.07.755_bib12","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.07.755_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2017.07.755_bib14","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.ahj.2004.09.015","article-title":"The American Heart Association Get With The Guidelines program","volume":"148","author":"Smaha","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.07.755_bib15","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/heartjnl-2014-307043","article-title":"Heart rate is associated with progression of atrial fibrillation, independent of rhythm","volume":"101","author":"Holmqvist","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2017.07.755_bib16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","article-title":"Progression from paroxysmal to persistent atrial fibrillation. Clinical correlates and prognosis","volume":"55","author":"de Vos","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.07.755_bib17","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for\u00a0atrial fibrillation in a population-based cohort. The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.07.755_bib18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.diabres.2015.06.006","article-title":"Diabetes mellitus as risk factor for atrial fibrillation hospitalization: incidence and outcomes over nine years in a region of Northern Italy","volume":"109","author":"Staszewsky","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jacc.2017.07.755_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3349\/ymj.2015.56.1.62","article-title":"Clinical characteristics and impact of diabetes mellitus on outcomes in patients with nonvalvular atrial fibrillation","volume":"56","author":"Huang","year":"2015","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jacc.2017.07.755_bib20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/dmrr.386","article-title":"Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10-year follow-up","volume":"19","author":"Klem","year":"2003","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jacc.2017.07.755_bib21","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.jacc.2016.09.944","article-title":"Causes of death in anticoagulated patients with atrial fibrillation","volume":"68","author":"G\u00f3mez-Outes","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.07.755_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ahj.2015.07.006","article-title":"Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: the ROCKET AF Trial","volume":"170","author":"Bansilal","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2017.07.755_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ehjcvp\/pvu024","article-title":"Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial","volume":"1","author":"Ezekowitz","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2017.07.755_bib24","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.hrthm.2015.01.025","article-title":"Glycated hemoglobin and risk of first episode stroke in diabetic patients with atrial fibrillation: a cohort study","volume":"12","author":"Saliba","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2017.07.755_bib25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1253\/circj.67.835","article-title":"Diabetes influences the cardiac symptoms related to atrial fibrillation","volume":"67","author":"Sugishita","year":"2003","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2017.07.755_bib26","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/eurheartj\/ehi376","article-title":"Diabetes, glucose level, and risk of sudden cardiac death","volume":"26","author":"Jouven","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2017.07.755_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/2013.jamainternmed.744","article-title":"Atrial fibrillation and the risk of sudden cardiac death: the Atherosclerosis Risk in Communities Study and Cardiovascular Health Study","volume":"173","author":"Chen","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2017.07.755_bib28","doi-asserted-by":"crossref","first-page":"e000916","DOI":"10.1161\/JAHA.114.000916","article-title":"Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation","volume":"3","author":"Sandhu","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2017.07.755_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jce.12602","article-title":"Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction","volume":"26","author":"Bunch","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2017.07.755_bib30","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2017.07.755_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijcard.2015.03.052","article-title":"Diabetes mellitus and atrial fibrillation: pathophysiological mechanisms and potential upstream therapies","author":"Goudis","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2017.07.755_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S2213-8587(16)00052-8","article-title":"Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"4","author":"Wu","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2017.07.755_bib33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jama.2015.10029","article-title":"Prevalence of and trends in diabetes among adults in the United States, 1988\u20132012","volume":"314","author":"Menke","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2017.07.755_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1536\/ihj.14-107","article-title":"Beneficial effects of pioglitazone on retardation of persistent atrial fibrillation progression in diabetes mellitus patients","volume":"55","author":"Liu","year":"2014","journal-title":"Int Heart J"},{"key":"10.1016\/j.jacc.2017.07.755_bib35","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/2047487315599892","article-title":"Risk of atrial fibrillation in diabetes mellitus: a nationwide cohort study","volume":"23","author":"Pallisgaard","year":"2016","journal-title":"Eur J Prev Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717389702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109717389702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T21:29:42Z","timestamp":1536701382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109717389702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0735109717389702"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2017.07.755","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Care Patterns and Outcomes in Atrial\u00a0Fibrillation Patients With and Without Diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2017.07.755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}